Synergism between propolis and hyperthermal intraperitoneal chemotherapy with cisplatin on Ehrlich ascites tumor in mice

Journal of Pharmaceutical Sciences

Volumn 102, Issue 12, 2013, Pages 4395-4405

  Oršolic̈, Nada ^a   Car, Nikola ^b   Lisičic̈, Duje ^a   Benkovic̈, Vesna ^a   Kneževic̈, Anica Horvat ^a   Đikić, Domagoj ^a   Petrik, Jõzsef ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b PLIVA CROATIA LTD   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

cancer chemopreveention; chemotherapy; cisplatin; ehrlich ascites tumor; Ehrlich ascites tumorp; food interaction; hyperthemia; hyperthermia; immunomodulation; immunotherapy; natural products; propolis; toxicity

Indexed keywords

CISPLATIN; CYTOTOXIC AGENT; PROPOLIS; UNCLASSIFIED DRUG; WATER SOLUBLE DERIVATIVE OF PROPOLIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CANCER SURVIVAL; CELL COUNT; CHEMOSENSITIVITY; COMET ASSAY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; EHRLICH ASCITES TUMOR; EHRLICH ASCITES TUMOR CELL; GENOTOXICITY; HYPERTHERMAL INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; IMMUNOSTIMULATION; MALE; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; TUMOR CELL DESTRUCTION;

CANCER CHEMOPREVEENTION; CHEMOTHERAPY; CISPLATIN; EHRLICH ASCITES TUMOR; EHRLICH ASCITES TUMORP; FOOD INTERACTION; HYPERTHEMIA; HYPERTHERMIA; IMMUNOMODULATION; IMMUNOTHERAPY; NATURAL PRODUCTS; PROPOLIS; TOXICITY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CISPLATIN; DRUG SYNERGISM; HYPERTHERMIA, INDUCED; IMMUNOTHERAPY; MACROPHAGES; MALE; MICE; PROPOLIS;

EID: 84888206056     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23755     Document Type: Article

References (61)

1. De Bree E, Rosing H, Michalakis J, Romanos J, Relakis K, Theodoropoulos PA, Beijnen JH, Georgoulias V, Tsiftsis DD,. 2006. Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination. Eur J Surg Oncol 32 (6): 666-670.
2. Orsolic̈ N, Bevanda M, Kujundzic̈ N, Plazonic A, Stajcar D, Kujundzic̈ M,. 2010. Prevention of peritoneal carcinomatosis in mice by combining hyperthermal intraperitoneal chemotherapy with the water extract from Burr parsley (Caucalis platycarpos L.). Planta Med 76 (8): 773-779.
3. Glockzin G, Schlitt HJ, Piso P,. 2010. Peritoneal carcinomatosis: Patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 7: 5.
4. Bevanda M, Orsolic N, Basic I, Vukojevic K, Benkovic V, Horvat Knezevic A, Lisicic D, Dikic D, Kujundzic M,. 2009. Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2. Int J Hyperthermia 2: 132-140.
5. Siddik ZH., 2003. Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279.
6. Brozovic G, Orsolic N, Knezevic F, Horvat Knezevic A, Benkovic V, Sakic K, Hrgovic Z, Bendelja K, Fassbender WJ,. 2009. Genotoxicity and cytotoxicity of cisplatin treatment combined with anaesthetics on EAT cells in vivo. Onkologie 6: 337-343.
7. Kosmider B, Zawlik I, Liberski PP, Osiecka R, Zyner E, Ochocki J, Bartkowiak J,. 2006. Evaluation of P53 and BAX gene expression and induction of apoptosis and necrosis by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-diamminedichloroplatinum(II) (cis-DDP) in human lymphocytes. Mutat Res 604: 28-35.
8. Lu Y, Cederbaum AI,. 2006. Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol Sci 89: 515-523.
9. Mansour HH, Hafez HF, Fahmy NM,. 2006. Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol 39: 656-661.
10. Lee CK, Son SH, Park KK, Park JH, Lim SS, Chung WY,. 2008. Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy induced toxicity in a mouse xenograft model of colon carcinoma. J Pharmacol Sci 106: 444-451.
11. Lee CK, Son SH, Park KK, Park JH, Lim SS, et al. 2008. Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice. Basic Clin Pharmacol Toxicol 103: 148-154.
12. Iraz M, Ozerol E, Gulec M, Tasdemir S, Idiz N, Fadillioglu E, Naziroglu M, Akyol O,. 2006. Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat. Cell Biochem Funct 24 (4): 357-361.
13. Oršolic̈ N, Bevanda M, Bendelja K, Horvat-Kneževic̈ A, Benkovic̈ V, Bašic̈ I,. 2008. Propolis and related polyphenolic compounds; their relevance on host resistance and interaction with chemotherapy. Scientific evidence of the use of propolis in ehtnomedicine. In Ethnopharmacology-Review book;, Oršolic̈ N, Bašic̈ I, Eds. Trivandrum, Kerala, India: Transworld Research Network, pp 223-250.
14. Van der Zee J,. 2002. Heating the patient: A promising approach? Ann Oncol 13: 1173-1184.
15. Conklin KA,. 2004. Cancer chemotherapy and antioxidants. J Nutr 134: 3201S-3204S.
16. Oršolic̈ N, Benkovic̈ V, Lisičic̈ D, Dikic̈ D, Erhardt J, Kneževic̈ AH,. 2010. Protective effects of propolis and related polyphenolic/flavonoid compounds against toxicity induced by irinotecan. Med Oncol 27 (4): 1346-1358.
17. Ozen S, Akyol O, Iraz M, Söǧüt S, Ozuǧurlu F, Ozyurt H, Odaci E, Yildirim Z,. 2004. Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. J Appl Toxicol 24 (1): 27-35.
18. Usia T, Banskota AH, Tezuka Y, Midorikawa K, Matsushige K, Kadota S,. 2002. Constituents of Chinese propolis and their antiproliferative activities. J Nat Prod 65: 673-676.
19. Kosalec I, Sankovic̈ K, Zovko M, Oršolic̈ N, Bakmaz M, et al. 2008. Antimicrobial and antioxidant activity of propolis from Croatia and Brazil: A comparative study. Scientific evidence of the use of propolis in ehtnomedicine. In Ethnopharmacology-Review book;, Oršolic̈ N, Bašic̈ I, Eds. Trivandrum, Kerala, India: Transworld Research Network, pp 175-194.
20. Oršolic̈ N, Bašic̈ I,. 2003. Immunomodulation by water-soluble derivate of propolis: A factor of antitumor reactivity. J Ethnopharm 84: 265-273.
21. Oršolic̈ N, Šver L, Terzic̈ S, Tadic̈ Z, Bašic̈ I,. 2003. Inhibitory effect of water-soluble derivative of propolis and its polyphenolic compounds on tumor growth and metastasing ability: A possible mode of antitumor action. Nutr Cancer 47: 156-163.
22. Oršolic̈ N, Brbot Šaranovic̈ A, Bašic̈ I,. 2005. Direct and indirect mechanism(s) of antitumor activity of propolis and its polyphenolic compounds. Planta Med 72: 14-19.
23. Oršolic̈ N, Kosalec I, Bašic̈ I,. 2005. Synergystic antitumor effect of polyphenolic components of water soluble derivative of propolis against Ehrlich ascites tumour. Biol Pharm Bull 28: 694-700.
24. Oršolic̈ N, Bašic̈ I,. 2007. Cancer chemoprevention by propolis and its polyphenolic compounds in experimental animals. In Recent progress in medicinal plants;, Singh VK, Govil JN, Arunahalam C, Eds. Vol. 17. Houston, Texas: Studium Press, pp. 55-113.
25. Sforcin JM., 2007. Propolis and the immune system: A review. J Ethnopharmacol 13: 1-14.
26. Fischer G, Vidor T,. 2008. Propolis as an immune system modulator substance. In Scientific evidence of the use of propolis in ethnomedicine;, Oršolic̈ N, Bašic̈ I, Eds. Trivandrum, Kerala, India: Transworld Research Network, pp 33-147.
27. Izuta H, Narahara Y, Shimazawa M, Mishima S, Kondo S, Hara H,. 2009. 1,1-diphenyl-2-picrylhydrazyl radical scavenging activity of bee products and their constituents determined by ESR. Biol Pharm Bull 32: 1947-1951.
28. Orsolic N, Sirovina D, Zovko Končic̈ M, Lackovic̈ G, Gregorovic̈ G,. 2012. Effect of Croatian propolis on diabetic nephropathy and liver toxicity in mice. BMC Complement Altern Med 12: 117.
29. Chen CN, Weng MS, Wu CL, Lin JK,. 2004. Comparison of radical scavenging activity, cytotoxic effects and apoptosis induction in human melanoma cells by Taiwanese propolis from different sources. eCAM 1: 175-185.
30. Oršolic̈ N., 2010. A review of propolis antitumour action in vivo and in vitro. JAAS 2 (1): 1-20.
31. Singh NP, McCoy MT, Tice RR, Schneider LL,. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 75: 184-191.
32. McKelvey-Martin VJ, Green MH, Schmezer P, Pool-Zobel BL, De Méo MP, Collins A,. 1993. The single cell gel electrophoresis assay (comet assay): A European review. Mutat Res 288: 47-63.
33. Collins AR., 2004. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 26: 249-261.
34. Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, et al. 2003. Recommendations for conducting the in vivo alkaline Comet assay. Mutagenesis 18: 45-51.
35. Kaplan EL, Meier P,. 1958. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-465.
36. Mantel N, Haenszel W,. 1959. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
37. Iraz M, Ozerol E, Gulec M, Tasdemir S, Idiz N, Fadillioglu E, Naziroglu M, Akyol O,. 2006. Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat. Cell Biochem Funct 24 (4): 357-361.
38. Naziroglu M, Karaoǧlu A, Aksoy AO,. 2004. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 195 (2-3): 221-230.
39. Kizilay A, Kalcioglu MT, Ozerol E, Iraz M, Gulec M, Akyol O, Ozturan O,. 2004. Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats. J Chemother 16 (4): 381-387.
40. Hahn GM, Strande DP,. 1976. Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. J Nati Cancer Inst 37: 1063-1067.
41. Halamikova A, Vrana O, Kasparkova J, Brabec V,. 2007. Biochemical studies of the thermal effects on DNA modifications by the antitumor cisplatin and their repair. Chembiochem 8 (16): 2008-2015.
42. Roti Roti JL,. 2007. Heat-induced alterations of nuclear protein associations and their effects on DNA repair and replication. Int J Hyperthermia 23: 3-15.
43. Takahashi A, Yamakawa N, Mori E, Ohnishi K, Yokota S, et al. 2008. Development of thermotolerance requires interaction between polymerase-beta and heat shock proteins. Cancer Sci 99: 973-978.
44. Komarova LN, Petin VG, Saenko AS,. 2007. The recovery parameters of DNA strand breaks of Ehrlich ascites cells after the combined action of ionizing radiation and hyperthermia. Radiats Biol Radioecol 47: 584-590.
45. Radons J, Multhoff G,. Immunostimulatory functions of membrane-bound and exported heat shock protein 70. Exerc Immunol Rev 11: 17-33.
46. Multhoff G, Mizzen L, Winchester CC, Milner CM, Wenk, Gross C, et al. 2003. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol Chem 384 (2): 267-279.
47. Gross C, Schmidt-Wolf IG, Nagaraj S, Gastpar R, Ellwart J, et al. 2003. Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells. Cell Stress Chaperones 8 (4): 348-360.
48. Benkovic V, Horvat Knezevic A, Brozovic G, Knezevic F, D strok signikic D, et al. 2007. Enhanced antitumor activity of irinotecan combinated with propolis and its polyphenolic compounds on Ehrlich ascites tumor in mice. Biomed Pharmacother 61: 292-297.
49. Meyn RE, Corry PM, Fletcher SE, Demetriades M,. 1979. Thermal enhancement of DNA strand breakage in mammalian cells treated with bleomycin. Int J Radiat Oncol Biol Phys 5: 1487-1489.
50. Meyn RE, Corry PM, Fletcher SE, Demetriades BS,. 1980. Thermal enhancement of DNA damage in mammalian cells treated with cis- diamminedichloroplatinum(II). Cancer Res 40: 1136-1139.
51. Schechter M, Stowe SM, Moroson H,. 1978. Effects of hyperthermia on primary and metastatic tumor growth and host immune response in rats. Cancer Res 38 (3): 498-502.
52. Joshi N, Duhan V, Lingwal N, Bhaskar S, Upadhyay P,. 2012. A djuvant properties of thermal component of hyperthermia enhanced transdermal immunization: Effect on dendritic cells. PLoS One 7 (2): e32067.
53. Ito A, Tanaka K, Honda H, Abe S, Yamaguchi H, Kobayashi T., 2003. Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. J Biosci Bioeng 96 (4): 364-369.
54. Muthana M, Multhoff G, Pockley AG,. 2010. Tumour infiltrating host cells and their significance for hyperthermia. Int J Hyperthermia 26 (3): 247-255.
55. Lindegaard JC, Radacic M, Khalil AA, Horsman MR, Overgaard J,. 1992. Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Importance of sequence, interval, drug dose, and temperature. Acta Oncol 31 (3): 347-351.
56. Asanami S, Shimono K,. 1999. The effect of hyperthermia on micronucleus induction by mutagens in mice. Mutat Res 446 (2): 149-154.
57. Metzner J, Bekemeier H, Weber FG,. 1982. Influence of flavonoids on capillary permeability, carrageenin edema and histamine and PGE2 spasms. Agents Actions Suppl 10: 129-134.
58. Oršolic̈ N, Bašic̈ I,. 2008. Polyphenols from propolis and plants in control of allergy and inflammation. Scientific evidence of the use of propolis in ehtnomedicine. In Ethnopharmacology-Review book;, Oršolic̈ N, Bašic̈ I, Eds. Trivandrum, Kerala, India: Transworld Research Network, pp 311-336.
59. Oršolic̈ N, Bašic̈ I,. 2008. Propolis and plant flavonoids in human allergies and inflammations. Scientific evidence of the use of propolis in ehtnomedicine. In Ethnopharmacology-Review Book., Oršolic̈ N, Bašic̈ I, Eds. Trivandrum, Kerala, India: Transworld Research Network, pp 337-376.
60. Akyol S, Ginis Z, Armutcu F, Ozturk G, Yigitoglu MR, Akyol O,. 2012. The potential usage of caffeic acid phenethyl ester (CAPE) against chemotherapy-induced and radiotherapy-induced toxicity. Cell Biochem Funct 30 (5): 438-443.
61. Ozturk G, Ginis Z, Akyol S, Erden G, Gurel A, Akyol O,. 2012. The anticancer mechanism of caffeic acid phenethyl ester (CAPE): Review of melanomas, lung and prostate cancers. Eur Rev Med Pharmacol Sci 16 (15): 2064-2068.